SCHEMBL23220486

SCHEMBL23220486

CCCCCCCCSCCCCCCCCOc1ccc(O)cc1

nearest known ligand 0.80

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR5A1 Q13285 1/20 0.80
LTA4H P09960 3/20 0.70
PLA2G4B P0C869 8/20 0.64
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54
TP53 P04637 2/20 0.53
TSHR P16473 1/20 0.53
NPC1 O15118 1/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
ALOX15 P16050 1/20 0.49
RAB9A P51151 1/20 0.49
HSD17B10 Q99714 1/20 0.49
RARB P10826 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1837360 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR
SCHEMBL4238973 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR
SCHEMBL2675357 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR
SCHEMBL337790 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR
SCHEMBL1834632 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR
SCHEMBL337505 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR
SCHEMBL1401769 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR
SCHEMBL1835315 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR
SCHEMBL21054750 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR
SCHEMBL337960 0.89 NR5A1 (1.00) NR5A1LTA4HPLA2G4BTP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10975104-B2 Boron-containing compound STELLA PHARMA CORPORATION (JP) 2021-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10975104-B2 Boron-containing compound HCCS, BRIX1, SCO2 NR5A1 627/4885LTA4H 4114/4885PLA2G4B 3907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.